Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.24.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenues $ 743 $ 810 $ 853
Research and development expenses (5,983) (7,763) (9,850)
General and administrative expenses (2,955) (3,143) (3,845)
Operating loss (8,195) (10,096) (12,842)
Total financial income (expense), net 561 (77) 227
Loss before taxes on income (7,634) (10,173) (12,615)
Taxes on income
Net loss (7,634) (10,173) (12,615)
Deemed dividend (2,590)
Total comprehensive loss $ (7,634) $ (10,173) $ (15,205)
Basic net loss per share (in Dollars per share) $ (0.01) $ (0.01) $ (0.03)
Weighted average number of ordinary shares used in computing basic net loss per share (in Shares) 1,278,333,912 815,746,293 553,079,638